R52G (p.Arg52Gly) variant of HTR2A (5-hydroxytryptamine receptor 2A)

R52G (p.Arg52Gly) in HTR2A (5-hydroxytryptamine receptor 2A) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.20 / 1. The record also includes population frequency data and structural context.

R52G (p.Arg52Gly) variant details